Forecasting Pharmaceutical Prices for Economic Evaluations When There Is No Market: A Review

@inproceedings{Akpinar2017ForecastingPP,
  title={Forecasting Pharmaceutical Prices for Economic Evaluations When There Is No Market: A Review},
  author={Ilke Akpinar and Philip Jacobs and Tien Dat Tran},
  booktitle={PharmacoEconomics - open},
  year={2017}
}
BACKGROUND Economic evaluation helps policy makers and healthcare payers make decisions on drug listing, coverage, and reimbursement. When economic evaluations are conducted before a product launch, the prices of the pharmaceuticals have to be forecast. OBJECTIVE The aim of this study was to examine the methods of establishing proxy prices and their accuracies compared with actual market prices after the product launch. METHODS We searched the literature for evaluations for drugs that were… CONTINUE READING
BETA
Tweets
This paper has been referenced on Twitter 9 times. VIEW TWEETS

From This Paper

Topics from this paper.

References

Publications referenced by this paper.
SHOWING 1-9 OF 9 REFERENCES

list of newly licensed drugs (2010–2016)

  • US FDUSFDA.
  • . http://www.centerwatch.com/drug-information/fda…
  • 2016
1 Excerpt

Similar Papers

Loading similar papers…